INGENIA
Live / Applied — Third extension granted (statement of use) (as of 14 Jan 2026)
What this means for you
Not registered yet, but its 07 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97707310
- Mark type
- Stylized text
- Filed
- 07 Dec 2022
- Published for opposition
- 21 May 2024
- Attorney of record
- Nicole Kinsley, Esq.
Goods and services
- Class 005 — Pharmaceuticals: House mark for pharmaceutical preparations for human use for the treatment of microvascular diseases and eye diseases
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields
Owner
- Ingenia Therapeutics Inc, Watertown, MA, US
- Ingenia Therapeutics Inc, Cambridge, MA, US
Prosecution history
- 15 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jan 2026 — SOU EXTENSION 3 GRANTED
- 14 Jan 2026 — SOU EXTENSION 3 FILED
- 14 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Apr 2025 — SOU EXTENSION 2 GRANTED
- 29 Apr 2025 — SOU EXTENSION 2 FILED
- 29 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jan 2025 — SOU EXTENSION 1 GRANTED
- 06 Jan 2025 — SOU EXTENSION 1 FILED
- 06 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 May 2024 — PUBLISHED FOR OPPOSITION